{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:02:38Z","timestamp":1784106158518,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007865","name":"University of Texas Medical Branch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jcjo.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T20:56:15Z","timestamp":1716411375000},"page":"e11-e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ocular screening for chronic graft-versus-host disease in patients with allogeneic hematopoietic stem cell transplant"],"prefix":"10.1016","volume":"60","author":[{"given":"Bryan G.","family":"Pearson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2122-0002","authenticated-orcid":false,"given":"Ray S.","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5220-5436","authenticated-orcid":false,"given":"Karima S.","family":"Khimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-5335","authenticated-orcid":false,"given":"Praveena K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2024.04.005_bib0001","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1007\/s00520-019-05207-z","article-title":"Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate","volume":"28","author":"Rosenthal","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11899-015-0265-2","article-title":"Quality of life in the chronic GVHD Consortium cohort: lessons learned and the long road ahead","volume":"10","author":"Krupski","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0003","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/09273948.2021.1939390","article-title":"A review of ocular graft-versus-host disease: pathophysiology, clinical presentation and management","volume":"29","author":"Carreno-Galeano","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","article-title":"Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Shikari","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0005","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0006","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/ICO.0b013e3181ca321c","article-title":"Ocular graft-versus-host disease after allogeneic stem cell transplantation","volume":"29","author":"Westeneng","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0007","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1188\/07.CJON.325-328","article-title":"Graft-versus-host disease: review and nursing implications","volume":"11","author":"Mattson","year":"2007","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0008","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD","volume":"31","author":"Dietrich-Ntoukas","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232579","article-title":"Refractory recurrent ocular graft versus host disease","volume":"12","author":"Greenan","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0010","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/ctr.12472","article-title":"Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus","volume":"28","author":"Lutz","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-10-182592","article-title":"Quality of life after allogeneic hematopoietic cell transplantation","volume":"114","author":"Pidala","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0012","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.sjopt.2013.06.007","article-title":"Ocular manifestations of graft-versus-host disease","volume":"27","author":"Nassar","year":"2013","journal-title":"Saudi J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0013","first-page":"351","article-title":"Ocular graft versus host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0014","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jtct.2021.05.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. The 2020 treatment of chronic GVHD report","volume":"27","author":"DeFilipp","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0017","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0018","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ophtha.2011.08.040","article-title":"Validation of measurement scales in ocular graft-versus-host disease","volume":"119","author":"Inamoto","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0019","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2006.02.003","volume":"12","author":"Couriel","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/bmt.2012.56","article-title":"Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria","volume":"47","author":"Jacobs","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0021","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41409-022-01733-3","article-title":"Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network","volume":"57","author":"Perovic","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0022","article-title":"A stepwise approach to the ocular manifestations of graft-vs.-host disease. Ophthalmic Pearls","author":"Blackburn","year":"2020","journal-title":"American Academy of Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tmrv.2018.11.003","article-title":"Peripheral blood or bone marrow stem cells? Practical considerations in hematopoietic stem cell transplantation","volume":"33","author":"Amouzegar","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2141.2007.06652.x","article-title":"The management and outcome of chronic graft-versus-host disease","volume":"138","author":"Fraser","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beha.2008.02.015","article-title":"Therapy of chronic graft-versus-host disease","volume":"21","author":"Arora","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0026","article-title":"Management of ocular GVHD","author":"Feldman","year":"2022","journal-title":"EyeWiki, American Academy of Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.04.005_bib0027","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1002\/acg2.62","article-title":"Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes consensus criteria","volume":"2","author":"Dierov","year":"2019","journal-title":"Adv Cell Gene Ther"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:23:25Z","timestamp":1737681805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418224001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0008418224001297"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.04.005","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular screening for chronic graft-versus-host disease in patients with allogeneic hematopoietic stem cell transplant","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}